Charles Elliott Sigal
Director · 2 filings · Latest: May 27, 2026
ALNYLAM PHARMACEUTICALS, INC.
Vir Biotechnology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
VIR | Charles Elliott Sigal | Director | May 27, 2026 | Grant/Award | $0.00 | 8,000 | — | 39,806 | |
ALNY | Charles Elliott Sigal | Director | May 20, 2026 | Grant/Award | $0.00 | 671 | — | 1,446 | |